Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
Certara2017年8月24日
Investigational Drug Gap Analysis
As the process of drug development has increased in cost and complexity, Certara has developed…
Certara2017年8月14日
Clinical Pharmacology—The Quarterback of Drug Development
Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…
Certara2017年8月14日
